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Purpose: Nitric oxide (NO) bioavailability is reduced during acute altitude exposure,
contributing toward the decline in physiological and cognitive function in this environment.
This study evaluated the effects of nitrate (NO−3 ) supplementation on NO bioavailability,
physiological and cognitive function, and exercise performance at moderate and
very-high simulated altitude.
Methods: Ten males (mean (SD): V˙O2max: 60.9 (10.1) ml·kg
−1·min−1) rested and
performed exercise twice at moderate (∼14.0% O2; ∼3,000 m) and twice at very-high
(∼11.7% O2; ∼4,300 m) simulated altitude. Participants ingested either 140 ml
concentrated NO−3 -rich (BRJ; ∼12.5 mmol NO
−
3 ) or NO
−
3 -deplete (PLA; 0.01 mmol
NO−3 ) beetroot juice 2 h before each trial. Participants rested for 45 min in normobaric
hypoxia prior to completing an exercise task. Exercise comprised a 45 min walk at 30%
V˙O2max and a 3 km time-trial (TT), both conducted on a treadmill at a 10% gradient
whilst carrying a 10 kg backpack to simulate altitude hiking. Plasma nitrite concentration
([NO−2 ]), peripheral oxygen saturation (SpO2), pulmonary oxygen uptake (V˙O2), muscle
and cerebral oxygenation, and cognitive function were measured throughout.
Results: Pre-exercise plasma [NO−2 ] was significantly elevated in BRJ compared with
PLA (p = 0.001). Pulmonary V˙O2 was reduced (p = 0.020), and SpO2 was elevated
(p= 0.005) during steady-state exercise in BRJ comparedwith PLA, with similar effects at
both altitudes. BRJ supplementation enhanced 3 km TT performance relative to PLA by
3.8% [1,653.9 (261.3) vs. 1718.7 (213.0) s] and 4.2% [1,809.8 (262.0) vs. 1,889.1 (203.9)
s] at 3,000 and 4,300 m, respectively (p= 0.019). Oxygenation of the gastrocnemius was
elevated during the TT consequent to BRJ (p= 0.011). The number of false alarms during
the Rapid Visual Information Processing Task tended to be lower with BRJ comparedwith
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PLA prior to altitude exposure (p = 0.056). Performance in all other cognitive tasks did
not differ significantly between BRJ and PLA at any measurement point (p ≥ 0.141).
Conclusion: This study suggests that BRJ improves physiological function and exercise
performance, but not cognitive function, at simulated moderate and very-high altitude.
Keywords: beetroot juice, nitrate, nitric oxide, altitude, exercise performance
INTRODUCTION
Exposure to altitude, an environment where the partial
pressure of oxygen (PO2) is reduced relative to sea-level,
has a profound negative effect on physiological function
and exercise performance (Bärtsch and Saltin, 2008). Arterial
oxygen saturation declines (Calbet and Lundby, 2009), muscle
metabolism is perturbed (Richardson et al., 2006; Vanhatalo et al.,
2011), and maximal oxygen consumption (V˙O2max) is decreased
(Wehrlin and Hallén, 2006; MacInnis et al., 2015). Accordingly,
exercise time to exhaustion (TTE) is reduced, and time-trial (TT)
performance is slower at altitude compared with sea-level (Fulco
et al., 1998). Interventions which help attenuate the decline in
physiological functioning and exercise performance at altitude
are therefore highly desirable. One strategy which has attracted
considerable recent attention in this regard is dietary nitrate
(NO−3 ) supplementation.
Dietary nitrate (NO−3 ) is an inorganic anion that can be
reduced into nitrite (NO−2 ) and subsequently nitric oxide (NO) in
the body. Elevating NO bioavailability via NO−3 supplementation
has been reported to restore muscle metabolic function and leg-
extension TTE to normoxic levels during exposure to moderate
simulated altitude (i.e., normobaric hypoxia; fraction of inspired
oxygen (FIO2): 14.5%; ∼2,800 m) (Vanhatalo et al., 2011).
Others have also observed increased peripheral oxygen saturation
(SpO2) (Masschelein et al., 2012; Muggeridge et al., 2014;
Bourdillon et al., 2015; Shannon et al., 2016), elevated muscle
oxygenation (Masschelein et al., 2012), improved endothelial
function (Bakker et al., 2015), and enhancements in high-
intensity TTE (Vanhatalo et al., 2011; Masschelein et al., 2012;
Kelly et al., 2014) and TT performance (Muggeridge et al., 2014;
Shannon et al., 2016) across a range of altitudes/ simulated
altitudes (FIO2: 11–15%; 2,500–5,000 m) consequent to NO
−
3
supplementation. Interestingly, one study reported that NO−3
supplementation was more effective in normobaric hypoxia
(FIO2 13.1%; ∼3,700 m) compared with normoxia (Kelly
et al., 2014). Indeed, NO−3 supplementation reduced oxygen
consumption and enhanced severe-intensity cycle ergometry
TTE in hypoxia, but not in normoxia (Kelly et al., 2014). As
the reduction of NO−2 into NO is potentiated as oxygen tension
declines (Castello et al., 2006), it is reasonable to suggest that the
effects of NO−3 supplementation on NO bioavailability, signaling,
and physiological responses might also increase with the degree
of hypoxia. Thus, NO−3 supplementation may be most effective
at very-high compared with moderate altitudes, although this
remains to be determined.
Previous studies exploring the performance effects of NO−3
supplementation at altitude/simulated altitude have employed
high-intensity leg-extension (Vanhatalo et al., 2011), cycle
ergometry (Masschelein et al., 2012; Kelly et al., 2014;
Muggeridge et al., 2014; Bourdillon et al., 2015; MacLeod et al.,
2015) or treadmill running (Arnold et al., 2015; Shannon et al.,
2016) as an exercise modality. However, exercise at altitude,
particularly hiking, or mountaineering, often involves prolonged
bouts of lower-intensity activity (Mellor et al., 2014). The effects
of NO−3 supplementation on key physiological or functional (e.g.,
time required to walk a given distance) parameters during this
type of activity are presently unclear. However, further study is
warranted given a relatively small number of people ascending to
altitude are trained athletes conducting high-intensity exercise,
yet thousands of individuals undertake altitude hiking and
mountaineering each year (Shah et al., 2015).
Several studies conducted at sea-level indicate that NO−3
supplementation might enhance cognitive function. An early
study in type II diabetics reported improved simple reaction time
following NO−3 supplementation (Gilchrist et al., 2014). More
recently, studies have reported elevated cerebral blood flow and
improved response accuracy during the Serial 3 Subtraction Task
in healthy individuals (Wightman et al., 2015), and improved
response time to cognitive tests at rest (Thompson et al.,
2016) and during prolonged intermittent exercise (Thompson
et al., 2015) in team sport players supplemented with dietary
NO−3 . The effect of NO
−
3 on cognitive function at altitude is
an attractive area for exploration, given cognitive function is
typically compromised at altitude, and this may have negative
safety implications for individuals hiking or mountaineering in
this environment (Abraini et al., 1998; Li et al., 2000; Taylor
et al., 2016). To the authors’ knowledge, only one study has been
conducted in this area to date. Lefferts et al. (2016) reported no
effects of a low dose of NO−3 (∼5 mmol) on resting cognitive
function in conditions of very-high simulated altitude (FIO2:
11.6%; ∼4,600 m). Nevertheless, it remains to be established
whether a higher dose of NO−3 might be necessary to enhance
cognitive function at altitude. Further, it is unclear whether
the effects of NO−3 on cognitive function might vary between
different altitudes, or whether NO−3 supplementation might
elicit different effects when conducted during hypoxic exercise
compared to rest. Further study is therefore warranted.
Against this background, the purpose of the present study was
to evaluate the effects of NO−3 supplementation on physiological
and cognitive function, and exercise performance at moderate
(3,000 m) and very-high (4,300 m) simulated altitude.
METHODS
Participants
Ten healthy men with a mean (SD) age of 23 (3) years, body mass
of 78.0 (12.5) kg, stature of 180.3 (8.1) cm, and sea-level maximal
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rate of oxygen uptake (V˙O2max) of 60.9 (10.1) ml·kg
−1·min−1
volunteered and provided fully informed written consent to
participate in the present study. All participants were non-
smokers, normotensive and not currently taking any medication.
None of the participants had traveled to an altitude >1,500m
during the preceding 3 months and all were currently residing
<500 m. The study received institutional ethical approval and
adhered to the principles of the Declaration of Helsinki.
Overview
Participants attended the laboratory on five separate occasions
within a 7 week period. Visits were separated by a minimum
of five and maximum of 12 days, and conducted at the
same time each day (±1 h) to minimize the influence of
circadian variance. On the first laboratory visit, participants
completed an incremental exercise test to volitional exhaustion
in normoxia to elucidate V˙O2max. Following a rest period
of ∼20 min, participants were then familiarized with the
experimental procedures. All subsequent visits involved exercise
in a normobaric hypoxic chamber (Sporting Edge, Sherfield
on Loddon, UK), situated ∼113m above sea-level. The FIO2
inside the normobaric hypoxic chamber was adjusted on a daily
basis, accounting for fluctuations in barometric pressure and
for 47 mmHg water vapor pressure (Conkin, 2011), to simulate
either a moderate altitude (FIO2 ∼14.5%; ∼3,000 m) or very-
high altitude (FIO2: ∼11.7%; ∼4,300 m). There were, in total,
four different experimental conditions, which were conducted
in a randomized order. These were: (1) 3,000m simulated
altitude with NO−3 -rich beetroot juice (BRJ) supplementation, (2)
3,000m simulated altitude with NO−3 -deplete placebo beetroot
juice (PLA) supplementation, (3) 4,300m simulated altitude
with BRJ supplementation; and, (4) 4,300m simulated altitude
with PLA supplementation. Prior to the experimental trials,
participants consumed either 140 ml concentrated BRJ (∼12.5
mmol NO−3 ) or PLA (∼0.01 mmol NO
−
3 ) (Beet It, James
White Ltd., Ipswich, UK) administered double blind, 2 h before
arriving at the laboratory. The NO−3 content of supplements was
determined via ozone-based chemiluminescence, as previously
described (Shannon et al., 2016). Participants were asked to avoid
alcohol and caffeine consumption, and abstain from intense
exercise for 24 h prior to each trial. Additionally, participants
were asked to avoid antibacterial mouthwash and chewing gum
throughout the study duration, given these have previously
been demonstrated to destroy the oral nitrate reducing bacteria
(Govoni et al., 2008). Participants gave verbal confirmation at
each trial that they had fully adhered to the stipulated pre-trial
controls.
Preliminary Trials
A two-part incremental test was conducted on a motorized
treadmill (Woodway, Cranlea, Birmingham, UK) at sea-level.
During the first part of the test, participants completed four
submaximal stages of 3 min duration, interspersed with 1 min
recovery periods. The treadmill speed was set at 1 km·h−1 for
the first stage, and increased by 1 km·h−1 each subsequent stage.
The treadmill gradient was set to 10% for all submaximal stages,
and participants were required to carry a 10 kg backpack. Gas
data obtained during this first part of the test was used to
calculate the V˙O2-speed relationship, and allow determination
of the appropriate treadmill speed for submaximal exercise in
the experimental trials. The exercise modality has previously
been utilized to approximate the physiological demands of
altitude hiking (Matu et al., 2017). Following four exercise stages,
participants rested for ∼5 min, after which the second phase of
the test commenced. Participants removed the backpack, and
the treadmill gradient was lowered to 1%. Participants were
then required to run at a fixed speed, which was determined
based around perceived fitness and eliciting an initial rating
of perceived exertion (RPE) of ∼12. The treadmill gradient
was increased by 1% every minute until participants reached
volitional exhaustion. Expired gas was monitored continuously
throughout exercise via an online gas analysis system, which was
calibrated prior to testing in accordance with the manufacturer’s
instructions (MedGraphics Ultima CPX, MGC Diagnostics,
MN, USA). Gas data obtained during the second part of the
test was used to determine V˙O2max (highest 30-s average in
V˙O2). Following a rest period of ∼20 min, participants were
familiarized with the cognitive testing procedures and the 3 km
walk test, as applied in the experimental trials.
Experimental Trials
Approximately 1 week after preliminary testing, participants
completed the first of four experimental trials. Experimental
trials commenced with ∼45 min of sitting at sea-level, during
which time pre-hypoxic exposure measurements were obtained.
Participants then entered the normobaric hypoxic chamber,
simulating an altitude of either 3,000 or 4,300 m, where they
rested for a further 45 min. An exercise period then commenced,
1.5 h after participant arrival at the laboratory and 3.5 h post-
supplementation. Exercise comprised 45 min of steady-state
walking at 30% V˙O2max, followed immediately by a 3 km TT.
An exercise intensity of 30% of sea-level V˙O2max elicited a
walking speed of 2.6 (0.6) km·h−1, which replicated the low
intensity nature of high altitude hiking (Matu et al., 2017; Mellor
et al., in press). During the TT, participants were informed of
the distance completed every 500 m, but were blinded to the
speed and time. All exercise was conducted at a 10% gradient
whilst participants carried a 10 kg backpack. Following exercise
participants rested in the normobaric hypoxic chamber for
a further 30 min, after which they returned to sea-level. A
schematic representation of the experimental trials protocol is
presented in Figure 1.
Measurements
Plasma [NO−2 ] and Blood Pressure
On arrival at the laboratory, participants were asked to rest in
a seated position for 5 min. An 8 ml venous blood sample was
collected via venepuncture from a vein in the antecubital fossa
into lithium heparin containing vacutainers (Becton Dickinson,
Plymouth, UK). Blood was immediately centrifuged for 3 min
at 5,000 rpm. Plasma was subsequently extracted into opaque
cryotubes (Argos Technologies, IL, USA), which were pre-
treated with 6.5 mM nethylmaleimide (NEM) and 0.1 mM
diethylenetriaminepentaacetic acid (DTPA) to minimize the
interchange between NO metabolites (Nagababu and Rifkind,
2010). Cryotubes were placed in a freezer at −80◦C, and later
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FIGURE 1 | A schematic representation of the experimental trials protocol. [NO−2 ], assessment of plasma nitrite concentration; BP, blood pressure; HR, heart rate;
SpO2, peripheral oxygen saturation; NIRS, near-infrared spectroscopy baseline; CT, cognitive testing; RPE, ratings of perceived exertion; TT, time-trial.
analyzed for plasma NO−2 concentration ([NO
−
2 ]) via ozone-
based chemiluminescence, as previously described (Shannon
et al., 2016). After blood sampling, participants rested for a
further 5 min. Blood pressure (BP) of the brachial artery was
thenmeasured using an automated sphygmomanometer (Omron
Healthcare Ltd., Kyoto, Japan). Four measures were acquired,
and the mean value of the final three measurements was used for
data analysis.
Peripheral Oxygen Saturation and Heart Rate
Following BP assessments, SpO2, and HR were measured
via pulse oximetry (Nellcor, Medtronic, Minneapolis, MN).
Subsequent measures of SpO2 and HR were conducted at rest in
hypoxia immediately prior to exercise, during the final 5 min of
steady-state walking, immediately following the TT, and prior to
exiting the hypoxic chamber.
Cognitive Function Assessment
Cognitive function was assessed at rest prior to hypoxic
exposure, at rest in hypoxia, during steady-state walking (after
15 min walking), and 5 min following TT completion. All
cognitive assessments were conducted using the Cambridge
Neuropsychological Test Automated Battery (CANTAB,
Cambridge Cognition, Cambridge, UK), and administered via a
touch screen tablet computer (IPad Air, Apple Inc., Cupertino,
CA, US). Three tests which have previously been applied to
evaluate the efficacy of nutritional supplementation on cognitive
function were administered (Maylor et al., 2006; Gilchrist et al.,
2014; Thompson et al., 2015; Wightman et al., 2015). These were
the Attention Switching Task (AST), Rapid Visual Information
Processing Task (RVP), and Spatial Span Task (SST). Tasks
were selected to provide information across different cognitive
domains including executive function, attention, and working
memory capacity.
Attention switching task
The AST is a test of executive function that measures the
participant’s ability to switch attention between stimuli, and
ignore task irrelevant information. White arrows are displayed
on a black background, with the arrows located on either the
left or right side of the screen, and pointing either to the left or
to the right. A cue is displayed at the same time as the arrows,
reading either “SIDE” or “DIRECTION.”When the “SIDE” cue is
presented, the participant is required to press a button on the left
or right of the computer screen corresponding to the side of the
screen where the arrow is presented, regardless of the direction
the arrow is pointing in. Conversely, when the “DIRECTION”
cue is presented, the participant is required to touch a button
on the left or right of the computer screen corresponding to
the direction the arrow is pointing, regardless of which side of
the screen the arrow is presented. The task administration time
was ∼8 min, including congruent stimuli (i.e., the location and
direction of the arrow are the same) and incongruent stimuli (i.e.,
the location and direction of the arrow are different). The total
number of correct responses and response times to the test were
analyzed.
Rapid visual information processing task
The RVP is a test of sustained attention. The participant is
presented with a white box in the center of the computer screen.
Single digits ranging from 2 to 9 are presented one at a time in a
pseudo-random order inside the box, appearing at a rate of 100
digits per minute. The participant is required to detect specific
3-digit sequences, including 2-4-6, 4-6-8, and 3-5-7. As soon as a
target sequence is detected, the participant is required to touch a
button on the screen. The task administration time was∼10 min.
The number target sequences correctly identified, response time
for correctly identified sequences, and number of false alarms
were analyzed.
Spatial span task
The SSP is a visuospatial analog of the Digit Span Task, and
measures working memory capacity. The participant is initially
presented with a black screen containing 9 white boxes. In a
variable sequence, some of the boxes briefly change color. The
participant is required to touch the boxes in the same order in
which they changed color. Initially, two boxes change color. For
every successful correct response, the number of boxes changing
color is increased by one, up to a maximum of nine boxes
changing color. The sequence and color change of boxes is varied
throughout the task. The test terminates when the participant
fails to correctly identify the sequence at a particular level on
three occasions, or correctly identifies all nine boxes that change
color during the final stage of the task. The task administration
time was ∼5 min. The longest sequence of correctly identified
boxes and mean number of attempts to pass were analyzed.
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Muscle Near-Infrared Spectroscopy
Near Infrared spectroscopy (NIRS) is a popular non-invasive
technique for evaluating tissue oxygenation (Neary, 2004). In the
present study, a dual wavelength (760 and 850 nm), light weight
(84 g), portable NIRS device (Portamon, ArtinisMedical Systems,
The Netherlands) was used for this purpose. During rest in
normoxia, following the measurement of resting plasma [NO−2 ],
BP, HR, and SpO2, a small patch was shaved on the left lateral
gastrocnemius. The portable NIRS device was secured to the leg
via a combination of surgical tape and an elastic non-compressive
bandage. The bandage also served the combined role of shielding
the device from extraneous light. The device placement was
replicated between trials with reference to local anatomical sites
and the small shaved patch on the leg. The device uses the
modified Beer-Lambert Law to monitor concentration changes
in oxyhaemoglobin ([O2Hb]), deoxyhaemoglobin ([HHb]), and
total hemoglobin ([tHb]). Values are expressed relative to the
first datum, which was collected following 5 min of seated
rest in normoxia. The [HHb] signal, which is regarded as
being essentially blood volume insensitive during exercise (Blasi
et al., 1993), was used to provide an estimate of fractional
O2 extraction in the area under interrogation (Masschelein
et al., 2012; Bailey et al., 2015). The sum of [O2Hb]and [HHb]
was used to calculate [tHb], which provides an index of the
change in regional blood volume (van Beekvelt et al., 2001).
This device also measures the Tissue Saturation Index (TSI)
using spatially resolved spectroscopy (SRS)—a measure which
provides a percentage oxygenation figure that reflects the ratio
between absolute values of oxygenated and total hemoglobin
plus myoglobin in the area under interrogation. The TSI is
calculated as: [O2Hb]/([O2Hb] + [HHb])
∗ 100. Data was
recorded at 10 Hz, and a differential pathlength factor (DPF) of
4.94 was used, in accordance with the findings of Duncan et al.
(1995). Mean muscle [O2Hb], muscle [HHb], and muscle [tHb]
were calculated for 5 min prior to and during each cognitive
testing period at rest and during exercise, and overall for the
3 km TT.
Cerebral Near-Infrared Spectroscopy
Cerebral oxygenation was also monitored via means of a cerebral
NIRS device. A dual wavelength (760 and 850 nm), light weight
(230 g), portable cerebral NIRS device (Octamon, ArtinisMedical
Systems, The Netherlands) was used for this purpose. The
unit consisted of a headband with 8 light emitters and two
light detectors, with an interoptode distance of 3.5 cm. The
device placement was replicated between trials by positioning
the bottom of the headband 1 cm above the eyebrows, and
the middle of the headband in the center of the forehead. This
device principally measures oxygenation of the medial prefrontal
cortex. As with the muscle tissue NIRS device, the cerebral NIRS
applies the modified Beer-Lambert Law to monitor changes in
[O2Hb], [HHb], and [tHb] relative to the first datum, which
was obtained following 5 min of seated rest in normoxia. Data
were recorded at 10 Hz and averaged for each variable across all
channels to provide an index of pre-frontal cortex oxygenation.
The DPF was adjusted according to the participants age (Duncan
et al., 1995). Concentration changes in cerebral [O2Hb], cerebral
[HHb], and cerebral [tHb] were calculated individually during
the 5 min period prior to each bout of cognitive tests, during each
cognitive task (at rest and during exercise), and overall for the
3 km TT.
Pulmonary Gas Exchange and Ratings of Perceived
Exertion
Pulmonary V˙O2, V˙CO2, and respiratory exchange ratio (RER)
were monitored throughout exercise, as previously described.
Mean V˙O2, V˙CO2, and RER were calculated for a 30 min period
during steady-state walking (10–40 min), and for the entire 3 km
TT. During the final 5 min steady-state exercise and immediately
post-TT, RPE was also recorded.
Statistical Analysis
Data were analyzed using IBM SPSS version 24 for Windows.
Two-way (supplement × altitude) repeated measures ANOVA
was employed to assess differences in plasma [NO−2 ], BP, HR,
SpO2, RPE, cognitive task performance, pulmonary gas exchange
data, muscle [HbO2], muscle [HHb], muscle [tHb], and TT
performance across experimental conditions. Cerebral [HbO2],
cerebral [HHb], and cerebral [tHb] were compared during
TT via two-way (supplement × altitude) ANOVA, and during
each cognitive testing period via three-way (supplement ×
altitude × task) repeated measures ANOVA. Significant three-
way interaction effects were explored using one-way ANOVA
and two-way interactions were explored using paired t-tests.
Statistical significance was set at p < 0.05 and Bonferroni
corrections were applied to all post-hoc tests. Cohen’s d is
presented for information on effect sizes. Effect sizes were
interpreted as≤0.2 trivial,>0.2 small,>0.6moderate,>1.2 large,
>2 very large, and >4 extremely large (Hopkins, 2004).
A statistical spreadsheet was also employed to derive
qualitative probabilistic inferences for TT performance data
(Hopkins, 2007). Verbal descriptors were used to express the
chance that the true value of the effect was beneficial, trivial,
or harmful, according to the following scale: <0.5%, “almost
certainly not”; 0.5–5%, “very unlikely not”; 5–25%, “unlikely”;
25–75%, “possibly”; 75–95%, “likely”; 95–99.5%, “very likely”;
>99.5%, “almost certainly.” The effect was deemed unclear
when an odds ratio of benefit to harm of <66 was identified,
corresponding to a 25% chance of benefit and 0.5% risk of
harm. Data are presented as means (SD) unless otherwise
stated. Individual responses are presented within figures where
appropriate to allow further exploration of the findings.
Power calculations were conducted using G∗Power (Faul et al.,
2007) to estimate an appropriate sample size. Based on previously
published data from our laboratory (Shannon et al., 2016), power
analysis indicated that 10 participants would provide >90%
power to detect a 3.2% change in TT performance with an alpha
level of 0.05.
RESULTS
All data is presented for n = 10, except for the pre-exercise
cognitive function data which is presented for n = 9 due to
missing data.
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Plasma [NO−2 ], and Blood Pressure
Prior to simulated altitude exposure, plasma [NO−2 ] was 630.9
(253.7), 203.9 (70.6), 555.3 (171.9), and 238.3 (125.3) nM for BRJ-
3000m, PLA-3000m, BRJ-4300m, and PLA-4300m, respectively.
Plasma [NO−2 ] was significantly elevated in BRJ compared with
PLA (main effect of supplement, p = 0.001, d = 2.22). There
was no difference in plasma [NO−2 ] prior to 3,000 and 4,300m
simulated altitude exposure (main effect of altitude, p = 0.612,
d = 0.08). Likewise, there was no supplement × altitude
interaction effect for plasma [NO−2 ] (p = 0.089). Pooled plasma
[NO−2 ] data for the two BRJ trials and two PLA trials is presented
in Figure 2.
Prior to simulated altitude exposure, mean arterial pressure
(MAP) was 88 (8), 92 (4), 88 (6), and 92 (11) mmHg for BRJ-
3000m, PLA-3000m, BRJ-4300m, and PLA-4300m, respectively.
MAP did not differ significantly between supplements (p= 0.323,
d = 0.41) or altitudes (p = 0.687, d = 0.07). Likewise, there was
no supplement× altitude interaction effect for MAP (p= 0.912).
Peripheral Oxygen Saturation, Heart Rate,
and Perceived Exertion
Resting SpO2 and HR were not significantly different between
conditions prior to hypoxic exposure (all effects p ≥ 0.110,
d ≤ 0.26, Table 1). There was a significant main effect
of supplement on SpO2 during the pre-exercise rest period
at simulated altitude and steady-state exercise period (both
p ≤ 0.017, d ≥ 0.28) reflecting an elevated SpO2 overall in
BRJ compared with PLA at these measurement points. During
simulated altitude exposure, SpO2 was lower at all measurement
points at 4,300m compared with 3,000m simulated altitude
(main effect of altitude, all p ≤ 0.002, d ≥ 1.37). There were
no supplement × altitude effects at any measurement point (all
p ≥ 0.127).
HRwas significantly higher at 4,300m compared with 3,000m
during the pre-exercise rest period at simulated altitude and
FIGURE 2 | Resting plasma nitrite concentration ([NO−2 ]) prior to simulated
altitude exposure following nitrate-rich beetroot juice (BRJ) and nitrate-deplete
placebo (PLA) supplementation. The closed bar represents the group mean
and SEM [NO−2 ] from the BRJ trials, and the open bar represents the group
mean and SEM [NO−2 ] from the PLA trials. Lines represent the individual
participant changes in plasma [NO−2 ] with BRJ supplementation.*Significant
main effect of supplement (p < 0.05).
steady-state exercise (main effect of altitude, both p ≤ 0.026,
d ≥ 0.38). HR was not significantly different between BRJ and
PLA at any measurement point (main effect of supplement, all
p≥ 0.132, d≤ 0.32). No supplement× altitude interactions were
detected for HR (all p ≥ 0.072).
During steady-state exercise, RPE was 10 (2), 10 (2), 12 (1),
and 11 (2) for BRJ-3000m, PLA-3000m, BRJ-4300m, and PLA-
4300m, respectively. RPE did not differ significantly between
supplements (p = 0.382, d = 0.18), but was significantly greater
at 4,300m compared with 3,000m (main effect of altitude,
p = 0.007, d = 0.93). There was no supplement × altitude
interaction effect (p = 1.000). During TT exercise, RPE was
19 (2), 19 (2), 19 (2), and 19 (1) for BRJ-3000m, PLA-3000m,
BRJ-4300m, and PLA-4300m, respectively. RPE did not differ
significantly between supplements (p = 0.604, d = 0.06) or
altitudes (p= 0.678, d= 0.06) during the TT. Likewise, there was
no supplement× altitude interaction effect for RPE (p= 0.879).
Pulmonary Gas Exchange
Steady-State Exercise
During steady-state exercise, mean pulmonary V˙O2 was 17.2
(3.9), 18.1 (3.9), 17.6 (4.0), and 18.5 (4.2) ml·kg−1·min−1 for BRJ-
3000m, PLA-3000m, BRJ-4300m, and PLA-4300m, respectively.
Pulmonary V˙O2 was significantly lower in BRJ compared with
PLA (main effect of supplement, p = 0.020, d = 0.21). There
was no effect of altitude on V˙O2 during steady-state exercise
(p = 0.298, d = 0.10), and no supplement × altitude interaction
was detected (p= 0.745).
Pulmonary V˙CO2 during steady-state exercise was 16.4 (3.7),
17.2 (3.1), 17.1 (4.1), and 17.6 (4.0) ml·kg−1·min−1 for BRJ-
3000m, PLA-3000m, BRJ-4300m, and PLA-4300m, respectively.
V˙CO2 was significantly lower in BRJ compared with PLA (main
effect of supplement, p = 0.035, d = 0.17), but not significantly
different between 3,000 and 4,300m simulated altitude (main
effect of altitude, p = 0.364, d = 0.11). There was no supplement
∗ altitude interaction effect (p= 0.906).
TABLE 1 | Group mean (SD) peripheral oxygen saturation (SpO2) and heart rate
(HR) following BRJ and PLA supplementation at 3,000 and 4,300m simulated
altitude.
Rest in
normoxia
Pre-exercise
rest in hypoxia
Steady-
state
exercise
TT Post-exercise
rest in hypoxia
SpO2
BRJ-3000m 98 (1) 91 (5)* 84 (2)* 77 (6) 88 (4)
PLA-3000m 98 (1) 89 (4) 80 (6) 76 (9) 89 (4)
BRJ-4300m 98 (1) 83 (5)*# 72 (5)*# 67 (6)# 83 (6)#
PLA-4300m 98 (1) 81 (4)# 70 (5)# 66 (8)# 79 (5)#
HR
BRJ-3000m 68 (13) 68 (15) 117 (13) 163 (12) 94 (11)
PLA-3000m 61 (9) 70 (13) 116 (7) 154 (12) 91 (8)
BRJ-4300m 67 (13) 72 (13)# 124 (9)# 158 (5) 87 (15)
PLA-4300m 67 (13) 75 (12)# 123 (10)# 160 (8) 93 (10)
*Significantly different from PLA (main effect of supplement, p < 0.05).
#Significantly different from 3,000m (main effect of altitude, p < 0.05).
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Respiratory exchange ratio (RER) during steady-state exercise
was 0.95 (0.05), 0.96 (0.06), 0.97 (0.05), and 0.95 (0.05) BRJ-
3000m, PLA-3000m, BRJ-4300m, and PLA-4300m, respectively.
RER did not differ significantly between supplements (p= 0.592,
d = 0.10) or altitudes (p = 0.835, d = 0.10). Likewise,
there was no supplement ∗ altitude interaction effect on RER
(p= 0.542).
TT Exercise
During TT exercise, mean pulmonary V˙O2 was 34.6 (6.3), 34.1
(5.4), 30.0 (3.9), and 29.7 (5.2) ml·kg−1·min−1 for BRJ-3000m,
PLA-3000m, BRJ-4300m, and PLA-4300m, respectively. V˙O2 was
significantly higher during TT exercise at 3000m compared with
4300m simulated altitude (main effect of altitude, p < 0.001,
d = 0.90). However, there was no difference in V˙O2 between BRJ
and PLA (main effect of supplement, p = 0.229, d = 0.09), and
no supplement× altitude interaction effect (p= 0.579).
Pulmonary V˙CO2 during TT exercise was 36.5 (7.3), 35.7
(6.4), 32.0 (4.4), and 31.6 (5.1) ml·kg−1·min−1 for BRJ-3000m,
PLA-3000m, BRJ-4300m, and PLA-4300m, respectively. V˙CO2
tended to be elevated in BRJ compared with PLA (main effect of
supplement, p = 0.058, d = 0.10), and was significantly greater
during exercise at 3,000m compared with 4,300m simulated
altitude (main effect of altitude, p= 0.011, d = 0.76). There were
no supplement ∗ altitude interaction effect (p= 0.745).
Respiratory exchange ratio (RER) during TT exercise was 1.05
(0.04), 1.05 (0.07), 1.06 (0.04), and 1.06 (0.06) for BRJ-3000m,
PLA-3000m, BRJ-4300m, and PLA-4300m, respectively, and was
no different between supplements (p = 0.969, d = 0.20) or
altitudes (p= 0.425, d= 0.18). Likewise, there was no supplement
∗ altitude interaction effect (p= 0.967).
Cognitive Function
Data for the cognitive test results is located in the Supplementary
data Table 1. There was a tendency toward a reduced number
of false alarms in the RVP task in BRJ compared with PLA
prior to altitude exposure, although this did not attain statistical
significance (main effect of supplement, p = 0.056, d = 0.30).
There was no significant difference in cognitive function for other
cognitive tests between BRJ and PLA at all measurement points
(main effect of supplement, all p ≥ 0.141, d ≤ 0.59). There was
a significant decline in cognitive function at 4,300m compared
with 3,000m during steady-state exercise for AST number of
correct responses, AST response time, and RVP response time
(main effect of altitude, all p ≤ 0.041, d ≥ 0.32). There was also
a significant decline in cognitive function at 4,300m compared
with 3,000m during the post-exercise measurement period for
AST response time, RVP number of correct responses, RVP
response time, and RVP false alarms (main effect of altitude, all
p ≤ 0.016, d ≥ 0.48). A tendency toward a reduced number of
correct responses at 4,300m compared with 3,000m was also
detected during the post-exercise period for AST, although this
did not attain significance (p = 0.053, d = 0.51). Significant
supplement × altitude interaction effects were detected for
AST number of correct responses during steady-state exercise
(p = 0.032), AST response time during the pre-exercise rest
period (p = 0.019), and SSP mean number of attempts to
pass during the post-exercise rest period (p = 0.040). However,
none of these achieved statistical significance during post-hoc
analysis once appropriate adjustments were made for multiple
comparisons (p ≥ 0.325, d ≤ 0.84).
Muscle Near-Infrared Spectroscopy
Muscle TSI did not differ significantly between BRJ and
PLA during steady-state exercise (main effect of supplement,
p = 0.139, d = 0.15), but was significantly higher in BRJ
compared with PLA during TT exercise (main effect of
supplement, p= 0.011, d= 0.71, Figure 3A). In the post-exercise
rest period, muscle TSI was significantly greater at 3,000m
compared with 4,300m (p = 0.020, d = 0.83). No supplement
× altitude interaction effects were observed (p ≥ 0.656).
Muscle O2Hb did not differ significantly between supplements
(all p ≥ 0.525, d ≤ 0.17, Figure 3B) or altitudes (all p ≥ 0.087,
d ≤ 0.53) at any measurement point. Likewise, there were no
supplement× altitude interaction effects (all p ≥ 0.205).
Muscle HHb did not differ significantly between BRJ and PLA
at any measurement point (all p ≥ 0.251, d ≤ 0.34, Figure 3C).
Muscle HHb was significantly greater at 4,300m compared with
3,000m during steady-state exercise (p = 0.007, d = 0.52), and
tended to be greater at 4,300m compared with 3,000m during
the post-exercise rest period (p= 0.051, d= 0.38). No significant
supplement × altitude interaction effects were observed (all
p ≥ 0.307).
Muscle tHb did not differ significantly between supplements
(all p ≥ 0.360, d ≤ 0.29, Figure 3D) or altitudes (all p ≥ 0.436,
d ≤ 0.20), and no supplement × altitude interaction effects were
detected (all p ≥ 0.209) at any measurement point.
Cerebral NIRS
Cerebral O2Hb tended to be greater in PLA compared with
BRJ during the TT (main effect of supplement, p = 0.056,
d = 0.55, Figure 4A), but did not differ significantly between
supplements at other measurement points (all p ≥ 0.487,
d ≤ 0.17). Cerebral O2Hb was significantly greater during
steady-state and TT exercise at 3,000m compared with 4,300m
simulated altitude (main effect of altitude, both p ≤ 0.001,
d ≥ 0.88). A significant effect of task was identified during
steady-state exercise (p < 0.001), reflecting an increase in
cerebral O2Hb during cognitive tasks compared with values
obtained in the 5 min walking period prior to cognitive tasks. A
significant supplement × altitude × task interaction effect was
also detected during steady-state exercise (p = 0.034), however
no significant effects were identified during post-hoc analysis
following adjustments for multiple comparisons (all p ≥ 0.909,
d ≤ 0.71).
Cerebral HHb was significantly greater in PLA compared with
BRJ during TT exercise (main effect of supplement, p = 0.047,
d = 0.58, Figure 4B), and tended to be greater during steady-
state exercise in PLA compared with BRJ (p = 0.053, d = 0.53).
Cerebral HHb was greater at 4,300m compared with 3,000m
during steady-state exercise and the post-exercise rest period
(both p ≤ 0.034, d ≥ 0.41). A significant supplement × altitude
interaction effect was observed during the pre-exercise rest
period (p = 0.047). Post-hoc analysis revealed greater cerebral
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FIGURE 3 | Muscle TSI (A), and the change in muscle oxyhaemoglobin
concentration ([HbO2]) (B), deoxyhaemoglobin concentration ([HHb]) (C), and
total hemoglobin concentration ([tHb]) (D) throughout experimental trials at
3,000 and 4,300m simulated altitude following nitrate-rich beetroot juice (BRJ)
and nitrate-deplete placebo (PLA) supplementation. Closed circles,
(Continued)
FIGURE 3 | Continued
BRJ-3000m; open circles, PLA-3000m; closed triangles, BRJ-4300m; open
triangles, PLA-4300m. Data are presented as mean and SEM. *Significant
main effect of supplement (p < 0.05). #Significant main effect of altitude
(p < 0.05).
HHb in PLA compared with BRJ at 3,000m during the pre-
exercise rest period (p < 0.001, d = 0.66).
Cerebral tHb was greater in PLA compared with BRJ
during TT exercise (main effect of supplement, p = 0.043,
d = 0.64, Figure 4C). There was no difference in cerebral tHb
between altitudes (p ≥ 0.064, d ≤ 0.42). A significant effect
of task was identified during steady-state exercise (p = 0.016),
reflecting the greater tHb during cognitive tasks relative to the
5 min pre-testing walking period. There was also a significant
supplement × altitude interaction during the pre-exercise rest
period (p = 0.021). Post-hoc analysis revealed greater tHb in
PLA compared with BRJ at 3,000m simulated altitude during the
pre-exercise rest period (p < 0.001, d = 0.63).
TT Performance
Completion times for the 3 km TT were 1,653.9 (261.3), 1,718.7
(213.0), 1,809.8 (262.0), and 1,889.1 (203.9) s for BRJ-3000m,
PLA-3000m, BRJ-4300m, and PLA-4300m respectively. There
was a significant main effect of supplement (p = 0.019, d = 0.31,
Figure 5), reflecting faster TT completion time overall in BRJ
compared with PLA. TT completion times were faster at 3,000m
compared with 4,300m (main effect of altitude, p < 0.001,
d = 0.72). No supplement × altitude interaction effect was
detected (p = 0.890). Individual threshold values of 42.6 s and
40.8 s were calculated for magnitude-based inferences at 3,000
and 4,300 m, respectively, based around the standardized effect
size of 0.2 multiplied by the between subject standard deviation
of the placebo trial at each altitude. Magnitude-based inferences
indicated a possibly beneficial (74.7%), unlikely trivial (24.9%),
most unlikely harmful (0.4%) effect of BRJ on TT performance
compared with PLA at 3,000 m. Additionally, the effect of BRJ on
TT performance at 4,300m altitude was deemed likely beneficial
(81.2%), unlikely trivial (17.9%), very unlikely harmful (0.9%)
compared with PLA.
DISCUSSION
The present study evaluated the effects of dietary NO−3
supplementation on physiological responses, cognitive function,
and exercise performance at moderate and very-high simulated
altitude. The primary findings are that NO−3 supplementation
elevated plasma [NO−2 ], increased SpO2 andmuscle TSI, reduced
steady-state V˙O2, and improved TT performance. Additionally,
NO−3 supplementation tended to reduce cerebral [O2Hb] and
significantly reduced cerebral [HHb] and [tHb] during TT
exercise. However, cognitive function was unaffected by NO−3
supplementation. Furthermore, the present data do not support
the notion that NO−3 supplementation is more effective at very-
high compared with moderate altitude.
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FIGURE 4 | The change in cerebral oxyhaemoglobin concentration ([HbO2]) (A), deoxyhaemoglobin concentration ([HHb]) (B), and total hemoglobin concentration
([tHb]) (C) throughout experimental trials at 3,000 and 4,300m simulated altitude following nitrate-rich beetroot juice (BRJ) and nitrate-deplete placebo (PLA)
supplementation. Values were obtained in the 5 min prior to cognitive tasks (PRE), and during the Attention Switching Task (AST), Rapid Visual Information Processing
Task (RVP), and Spatial Span Task (SSP). Closed circles, BRJ-3000m; open circles, PLA-3000m; closed triangles, BRJ-4300m; open triangles, PLA. Data are
presented as mean and SEM. 4300m *Significant main effect of supplement (p < 0.05). #Significant main effect of altitude (p < 0.05). †Significant main effect of task
(p < 0.05). §Significant supplement x altitude interaction (p < 0.05).
NO Bioavailability and Blood Pressure
In the present investigation, plasma [NO−2 ] was significantly
elevated consequent to NO−3 supplementation, which
substantiates previous research in this area (Webb et al.,
2008; Bailey et al., 2009; Vanhatalo et al., 2010, 2011; Wylie
et al., 2013; Shannon et al., 2016, 2017). NO generation via
L-arginine appears to be blunted in hypoxic conditions (Shaul
et al., 1993; Fish et al., 2007). Conversely, the reduction of NO−2
Frontiers in Physiology | www.frontiersin.org 9 June 2017 | Volume 8 | Article 401
Shannon et al. Nitrate Supplementation at Simulated Altitude
FIGURE 5 | Performance in the 3 km time-trial (TT) at 3,000m (A) and
4,300m (B) simulated altitude following nitrate-rich beetroot juice (BRJ) and
nitrate-deplete placebo (PLA) supplementation. The closed bars depicts the
mean and SEM performance times from the BRJ trials at each altitude, and
the open bar represents the mean and SEM performance times from the PLA
trials at each altitude. Lines represent the individual participant changes in
performance times with BRJ supplementation. *Significant main effect of
supplement (p < 0.05).
into NO is potentiated at low oxygen tensions (Castello et al.,
2006). Consequently, the increase plasma [NO−2 ] observed
following NO−3 supplementation may be especially effective
at maintaining or enhancing NO bioavailability and signaling
in hypoxic conditions, including the moderate and very-high
altitude environments simulated in this study.
Elevated NO bioavailability following NO−3 supplementation
might be expected to lower BP, due to NO-dependent relaxation
of smooth muscle and subsequent vasodilation (Larsen et al.,
2006; Webb et al., 2008; Vanhatalo et al., 2010; Siervo et al.,
2013, 2015). However, in the present study there was no
apparent difference in resting MAP assessed prior to simulated
altitude exposure between BRJ and PLA. This is also similar
to the findings of a recent study by our group, in which
trained runners/triathletes showed no change in MAP following
administration of an identical NO−3 dose, despite substantial
increases in plasma [NO−2 ] (Shannon et al., 2017). Recently,
Ashworth et al. (2015) reported a significant positive relationship
between baseline BP and the change in BP following ingestion of
a high-NO−3 diet. Thus, it seems plausible that the already low
BP in our participants limited the capacity to further reduce BP
following NO−3 supplementation.
Pulmonary Gas Exchange, Peripheral
Oxygen Saturation, and Muscle
Oxygenation
In accordance with multiple previous investigations in both
normoxia (Larsen et al., 2007; Bailey et al., 2009; Vanhatalo et al.,
2010; Pawlak-Chaouch et al., 2016) and hypoxia (Masschelein
et al., 2012; Kelly et al., 2014; Muggeridge et al., 2014; Shannon
et al., 2016), NO−3 supplementation reduced V˙O2 during steady-
state exercise. The novelty in our findings is that we demonstrate
this reduction in V˙O2 during simulated altitude hiking, a
finding with practical relevance for the thousands of individuals
who ascend to altitude for this purpose each year. This was
accompanied by an elevated SpO2 during steady-state exercise,
and a greater muscle TSI during TT exercise consequent to
NO−3 supplementation. Collectively these data might indicate
a reduced tissue oxygen extraction during exercise with NO−3
supplementation. NO−3 ingestion does not appear to “shift”
metabolism toward non-oxidative means of ATP resynthesis
(Bailey et al., 2010), and did not alter substrate oxidation in
this study as indicated by similar RER values in BRJ and
PLA. Therefore, it is likely that these effects reflect a genuine
improvement in exercise efficiency (i.e., less oxygen is required
for a given work rate). Mechanistically, this could be explained
by an improved efficiency of muscle contraction, such that the
ATP and oxygen requirements for a particular rate of force
generation are reduced (Bailey et al., 2010). Alternatively, NO−3
supplementation has been reported to improve the efficiency of
mitochondrial ATP resynthesis, an effect likely attributable to
reduced proton leak through the ATP/ADP translocase protein
(ANT) and possibly uncoupling protein 3 (UCP3), thus lowering
the oxygen cost of ATP regeneration (Larsen et al., 2011).
However, recent data question whether mitochondrial efficiency
is improved with beetroot juice, or whether this effect might
be restricted to sodium-NO−3 supplementation (Whitfield et al.,
2015). Contrasting the mechanisms of action of these two NO−3
vehicles may be a potential avenue for future research (Kemp,
2016).
Interestingly, in a study by Bourdillon et al. (2015), NO−3
supplementation increased pulmonary ventilation and elevated
SpO2 during exercise in hypoxia. A higher ventilation has
previously been associated with increased SpO2 (Benoit et al.,
1995). Thus, increased ventilation could contribute toward
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the elevated SpO2 with NO
−
3 supplementation in hypoxia.
Ventilation-related increases in SpO2 might also be expected
to increase muscle oxygenation, given an elevated SpO2 would
increase the pressure gradient driving oxygen diffusion from
the blood to the tissue (Masschelein et al., 2012). However,
the increased SpO2 (during steady-state exercise) and elevated
muscle TSI (during TT exercise) occurred during different phases
of the exercise test in this study, thus questioning the link
between these variables. An acknowledged limitation of this
study is that we did not obtain ventilation data, and as such it
is unclear whether this parameter was altered following NO−3
supplementation.
Cognitive Function and Cerebral
Oxygenation
Some (Gilchrist et al., 2014; Thompson et al., 2015, 2016;
Wightman et al., 2015) but not all (Kelly et al., 2013; Bondonno
et al., 2014; Thompson et al., 2014) studies conducted at sea-
level have reported beneficial effects of NO−3 supplementation
on cognitive function. Prior to this investigation, to the authors’
knowledge only one study had evaluated the effects of NO−3
supplementation on cognitive function at simulated altitude
(Lefferts et al., 2016). Lefferts et al. (2016) reported a significant
decline in short-termmemory, information processing efficiency,
and emotional recognition during rest at simulated altitude
(FIO2: 11.6%; 4,600 m) compared with sea-level. However, there
was no difference in cognitive performance between NO−3 and
placebo conditions. Likewise, middle cerebral artery blood flow,
an index of neurovascular coupling, was unchanged following
NO−3 supplementation. In the present study, cognitive function
was compromised during exercise and the post-exercise rest
period at 4,300m compared with 3,000m simulated altitude,
as indicated by either slower response times or a decreased
number of correct responses in the AST and RVP tasks.
Resting cognitive function did not differ between supplements at
simulated altitude, which is in accordance with the findings of
Lefferts et al. (2016). Extending these findings, the present study
demonstrated no effect of NO−3 supplementation on cognitive
function during or following exercise.
The previously reported beneficial effects of NO−3
supplementation on cognitive function may be related to
alterations in cerebral blood flow, in particular by ensuring
optimal delivery of blood (and thus oxygen) to match neural
activity (i.e., enhanced neurovascular coupling) (Wightman
et al., 2015). In elderly individuals, NO−3 supplementation
enhanced perfusion to areas of the brain known to play a
role in executive function (Presley et al., 2011). Furthermore,
NO−3 supplementation has been reported to facilitate a faster,
smaller, and more homogenous haemodynamic response to
visual stimulation (Aamand et al., 2013), and result in an initial
increase in cerebral blood flow during cognitive tasks, followed
by a consistent reduction in cerebral blood flow during less
demanding cognitive tasks (Wightman et al., 2015). In the latter
study, these blood flow changes also coincided with improved
cognitive performance (Wightman et al., 2015). We observed no
difference in pre-frontal cortex [tHb] changes between NO−3 and
placebo supplementation during the cognitive testing periods.
Interestingly, however, NO−3 supplementation decreased the
change in cerebral [tHb] during the TT, which might be a
consequence of lower blood flow to the pre-frontal cortex
during the TT in BRJ compared with PLA. Cerebral blood
flow changes at altitude are largely determined by four key
reflex mechanisms. These are the hypoxic ventilatory response,
hypercapnic ventilatory response, hypoxic cerebral vasodilation,
and hypocapnic cerebral vasoconstriction (Ainslie and Subudhi,
2014). It is possible that one or more of these variables may have
been influenced by NO−3 supplementation, with a concomitant
effect on cerebral blood flow.
As mentioned, Bourdillon et al. (2015) observed an
increase in the hypoxic ventilatory response following NO−3
supplementation, which might result in a lower cerebral blood
flow by elevating arterial oxygen tensions and decreasing arterial
carbon dioxide tensions (Ainslie and Subudhi, 2014). Although
we did not assess ventilation in this study, it seems unlikely
that a ventilation-related increase in arterial oxygen content
accounts for the lower [tHb] in BRJ compared with PLA, given
SpO2 did not differ between supplements during the TT. A
reduction in arterial carbon dioxide tensions could result in
cerebral vasoconstriction and hence reduced cerebral blood
flow, accounting for the reduced [tHb] during the TT with
NO−3 supplementation. Arterial carbon dioxide tension was
not evaluated in the present study. However, Bourdillon et al.
(2015) previously reported no effects of NO−3 supplementation
on arterial carbon dioxide pressure or end tidal carbon dioxide,
which brings into question this mechanism. Alternatively, it
is possible that differences in cerebral [tHb] resulted from
differences in cerebral activation as a consequence of the higher
mean power in BRJ (given time to complete the 3 km TT was
lower) compared with PLA (Brümmer et al., 2011).
Cerebral [HHb] was significantly lower during TT exercise,
and tended to be lower during steady-state exercise (which
involved simultaneous cognitive tasks) following NO−3
supplementation. A significant supplement× altitude interaction
effect was also observed during the pre-exercise rest period,
indicating reduced changes in cerebral [HHb] specifically at
3,000m simulated altitude consequent to NO−3 supplementation.
This may indicate a lower cerebral oxygen extraction in the
pre-frontal cortex following NO−3 supplementation during
these measurement periods. Alternatively, as both cerebral
[O2Hb] and [tHb] were also lower during the TT with BRJ,
these findings may reflect a smaller volume of blood in the area
under investigation, possibly as a consequence of differences
in cerebral blood flow as discussed above. Interestingly, and
in contrast to our findings, Masschelein et al. (2012) reported
no change in cerebral [O2Hb], [HHb], or [tHb] in conditions
of extreme simulated altitude (FIO2 11%; 5,000 m) with
NO−3 supplementation. This discordance in findings could be
related to the different altitudes simulated in this study and
by Masschelein et al. (2012). In hypoxia, cerebral blood flow
increases to ensure adequate delivery of oxygen to the brain, with
greater changes in blood flow observed at higher compared with
lower altitudes (Ainslie and Subudhi, 2014). Thus, it is possible
that NO−3 may be ineffective at influencing cerebral oxygenation/
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blood flow at extreme but not moderate or high altitude,
given the comparably greater hyperaemic response in the
former.
TT Performance
The effects of NO−3 supplementation on exercise TTE and/or
TT performance at simulated altitude have been evaluated in
a number of previous studies, with some (Vanhatalo et al.,
2011; Masschelein et al., 2012; Kelly et al., 2014; Muggeridge
et al., 2014; Shannon et al., 2016) but not all (Arnold et al.,
2015; Bourdillon et al., 2015; MacLeod et al., 2015) reporting
beneficial effects. In contrast to previous studies which have
employed high-intensity leg-extension (Vanhatalo et al., 2011),
cycle ergometry (Masschelein et al., 2012; Kelly et al., 2014;
Muggeridge et al., 2014; Bourdillon et al., 2015; MacLeod et al.,
2015), or treadmill running (Arnold et al., 2015; Shannon et al.,
2016) exercise protocols at simulated altitude, we evaluated
the effects of NO−3 supplementation using a protocol which
more closely replicates the demands of altitude hiking. For this
purpose, our participants were required to complete a 3 km
uphill (10% gradient) treadmill test whilst carrying a weighted
(10 kg) backpack. We observed a 3.8 and 4.2% improvement in
performance in BRJ compared with PLA at 3,000 and 4,300m
simulated altitude, respectively. The effects of BRJ on 3 km TT
performance were deemed to be “possibly beneficial” and “likely
beneficial” at 3,000 and 4,300m simulated altitude, respectively
(i.e., similar beneficial changes at both simulated altitudes). BRJ
supplementation was also deemed “most unlikely harmful” and
“very unlikely harmful” (i.e., both <1% chance harmful) for
performance at 3,000 and 4,300m simulated altitude respectively,
suggesting adverse performance effects are unlikely with BRJ
supplementation. Thus, BRJ supplementationmay have potential
beneficial applications for individuals hiking at altitude, perhaps
in situations where they are required to cover a particular
distance quickly, such as in response to changing weather
conditions or to ensure completion of a hike within daylight
hours.
Several mechanisms have been suggested to explain
the beneficial effects of NO−3 supplementation on exercise
performance. In particular, and as mentioned, NO−3 has been
proposed to enhance the efficiency of muscle contraction (Bailey
et al., 2010) and mitochondrial respiration (Larsen et al., 2011).
Such effects might account for the lower V˙O2 and elevated SpO2
observed in the present study following NO−3 supplementation,
and may also be expected to enhance performance by allowing a
higher work rate to be maintained for a given V˙O2.
The effects of NO−3 supplementation on muscle and cerebral
oxygenation might also be relevant from a performance
perspective. The greater muscle TSI observed during TT
exercise with NO−3 , reflective of greater muscle oxygenation,
could be beneficial by enhancing rates of oxidative ATP
resynthesis, and limiting phosphocreatine breakdown and rates
of anaerobic glycolysis. This might be beneficial by attenuating
the accumulation of fatigue associated metabolites, such as
H+, Pi, and ADP (Vanhatalo et al., 2011). Furthermore, it
has been suggested that cortical deoxygenation during exercise
might limit performance by compromising executive functions
and contributing toward the decision to cease exercise, with
this effect particularly apparent in hypoxia (Subudhi et al.,
2009). It is therefore possible that the beneficial effects of
NO−3 supplementation on performance might also partly be
accounted for by the reduced cerebral deoxygenation during TT
exercise.
Strengths and Limitations
The present study makes an important contribution toward our
understanding of the applications of NO−3 supplementation for
individuals exercising at altitude. Notably, our data indicate
potential physiological and performance benefits of NO−3
supplementation during hiking, which is a popular form
of activity amongst individuals ascending to altitude. It is
particularly promising that these effects occurred following
acute NO−3 consumption, such that individuals ascending to
altitude may not require prolonged time consuming and costly
supplementation strategies to elicit potentially beneficial effects.
Nevertheless, certain limitations should be acknowledged.
Firstly, our research was conducted in a normobaric hypoxic
chamber which simulated the low PO2 of altitude by reducing
the FIO2. This exercise environment allowed greater control over
potentially confounding variables vs. testing at terrestrial altitude,
and helped minimize participant burden. Recent work has
also reported broadly similar responses to normobaric hypoxia
and terrestrial altitude (Woods et al., 2017), suggesting that
normobaric hypoxia is a reasonable surrogate for the genuine
high-altitude environment. Nevertheless, further research is
warranted to confirm whether the beneficial effects of NO−3
supplementation observed in the present investigation also
manifest at terrestrial altitude. It is noteworthy that one
recent study reported improvements in flow mediated dilation
(FMD) following NO−3 ingestion during a trek to 3,700m
terrestrial altitude (Bakker et al., 2015), suggesting the potential
capacity to alter some physiological parameters at genuine
high altitude with this supplement. The relatively modest
sample size of the present study may also be regarded as a
limitation. However, our number of participants is similar to
several previous investigations that have reported significant
beneficial effects of NO−3 supplementation (e.g., Bailey et al.,
2009; Lansley et al., 2011; Breese et al., 2013; Wylie et al.,
2013).
CONCLUSION
Relative to placebo, NO−3 supplementation reduced steady-
state V˙O2, increased peripheral and muscle oxygenation,
and improved TT performance during hiking type activity
at moderate and very-high simulated altitude. NO−3
supplementation also elicited changes to cerebral blood
oxygenation, although no differences in cognitive function were
observed compared with placebo. These findings suggest that
NO−3 supplementation may offer some beneficial physiological
effects for individuals conducting hiking type activity at
moderate and very-high altitude. Conversely, the current data
do not support a beneficial effect of NO−3 supplementation on
cognitive function at altitude.
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